LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.73 | 84.90 | 23 | 3254 | 0.0071 | -0.2198 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.73 | 84.90 | 915 | 3254 | 0.2812 | 0.5714 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.73 | 84.90 | 458 | 3254 | 0.1407 | 0.3777 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.73 | 84.90 | 1112 | 3254 | 0.3417 | 0.6307 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.43 | 84.90 | 22 | 3459 | 0.0064 | -0.2231 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.43 | 84.90 | 856 | 3459 | 0.2474 | 0.5404 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.43 | 84.90 | 384 | 3459 | 0.1110 | 0.3260 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.43 | 84.90 | 1092 | 3459 | 0.3156 | 0.6121 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.14 | 84.90 | 23 | 3682 | 0.0062 | -0.2135 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.14 | 84.90 | 943 | 3682 | 0.2561 | 0.5569 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.14 | 84.90 | 254 | 3682 | 0.0690 | 0.2232 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.14 | 84.90 | 1081 | 3682 | 0.2936 | 0.5965 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.84 | 84.90 | 24 | 4003 | 0.0060 | -0.2033 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.84 | 84.90 | 862 | 4003 | 0.2153 | 0.5173 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.84 | 84.90 | 143 | 4003 | 0.0357 | 0.0983 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.84 | 84.90 | 1063 | 4003 | 0.2655 | 0.5756 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.55 | 84.90 | 27 | 4287 | 0.0063 | -0.1833 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.55 | 84.90 | 824 | 4287 | 0.1922 | 0.4943 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.55 | 84.90 | 80 | 4287 | 0.0187 | -0.0104 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.55 | 84.90 | 936 | 4287 | 0.2183 | 0.5283 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.25 | 84.90 | 34 | 4539 | 0.0075 | -0.1473 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.25 | 84.90 | 908 | 4539 | 0.2000 | 0.5111 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.25 | 84.90 | 53 | 4539 | 0.0117 | -0.0788 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.25 | 84.90 | 982 | 4539 | 0.2163 | 0.5318 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.95 | 84.90 | 33 | 4952 | 0.0067 | -0.1488 | MN20160318_Q02 | J14 |